|
|
||||||||
Journal of Lipid Research, Vol. 13, 680-686, September 1972
Copyright © 1972 by Lipid Research, Inc.
The Saul R. Korey Department of Neurology and the Department of Biochemistry, Albert Einstein College of Medicine of Yeshiva University, Bronx, New York 10461
Gangliosides were isolated from human, bovine, and rabbit plasma and were quantified by gas-liquid chromatography. Purification was achieved by sequential use of partitioning in solvents, DEAE-Sephadex chromatography, base treatment, and silicic acid chromatography. Human and bovine plasma yielded slightly more than 1 µmole of lipid-bound sialic acid/100 ml; for rabbit plasma the value was 0.28 µmole/100 ml. The total bovine plasma ganglioside fraction contained equal amounts of N-acetylneuraminic and N-glycolylneuraminic acids, rabbit plasma gangliosides had about 1% of the latter, and the human plasma sample contained only the former. Thin-layer chromatography revealed important differences among the plasmas from the three species, but all possessed hematosides and hexosamine-containing gangliosides. The approximate ratios of these two categories, based on sialic acid content, were (hematosides: hexosamine-type): human, 2:1; rabbit, 3:2; and bovine, 2:3. The fatty acid compositions of both categories were characteristic of extraneural gangliosides and included six major acids: palmitic, stearic, behenic, tricosanoic, lignoceric, and nervonic. The major long-chain base in each sample was sphingosine, while only a trace of the C20 isomer was detected.
Supplementary key words hematosides sialic acid fatty acids sphingosine bases DEAE-Sephadex
Submitted on January 21, 1972
Accepted on May 24, 1972
This article has been cited by other articles:
![]() |
Y. Li, D. Zhou, C. Xia, P. G. Wang, and S. B. Levery Sensitive quantitation of isoglobotriaosylceramide in the presence of isobaric components using electrospray ionization-ion trap mass spectrometry Glycobiology, February 1, 2008; 18(2): 166 - 176. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Li, S. Teneberg, P. Thapa, A. Bendelac, S. B. Levery, and D. Zhou Sensitive detection of isoglobo and globo series tetraglycosylceramides in human thymus by ion trap mass spectrometry Glycobiology, February 1, 2008; 18(2): 158 - 165. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Popa, A. Pons, C. Mariller, T. Tai, J.-P. Zanetta, L. Thomas, and J. Portoukalian Purification and structural characterization of de-N-acetylated form of GD3 ganglioside present in human melanoma tumors Glycobiology, April 1, 2007; 17(4): 367 - 373. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. Todeschini, J. N. Dos Santos, K. Handa, and S.-i. Hakomori Ganglioside GM2-Tetraspanin CD82 Complex Inhibits Met and Its Cross-talk with Integrins, Providing a Basis for Control of Cell Motility through Glycosynapse J. Biol. Chem., March 16, 2007; 282(11): 8123 - 8133. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Sonnino, L. Mauri, V. Chigorno, and A. Prinetti Gangliosides as components of lipid membrane domains Glycobiology, January 1, 2007; 17(1): 1R - 13R. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Alaniz, R. D. Lardone, S. L. Yudowski, M. I. Farace, and G. A. Nores Normally Occurring Human Anti-GM1 Immunoglobulin M Antibodies and the Immune Response to Bacteria Infect. Immun., April 1, 2004; 72(4): 2148 - 2151. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Matsuda, O. Suzuki, A. Oshima, Y. Yamamoto, A. Noguchi, K. Takimoto, M. Itoh, Y. Matsuzaki, Y. Yasuda, S. Ogawa, et al. Chemical chaperone therapy for brain pathology in GM1-gangliosidosis PNAS, December 23, 2003; 100(26): 15912 - 15917. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Popa, C. Vlad, J. Bodennec, and J. Portoukalian Recovery of gangliosides from aqueous solutions on styrene-divinylbenzene copolymer columns J. Lipid Res., August 1, 2002; 43(8): 1335 - 1340. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Toledo, E. Suzuki, S. B. Levery, A. H. Straus, and H. K. Takahashi Characterization of monoclonal antibody MEST-2 specific to glucosylceramide of fungi and plants Glycobiology, January 1, 2001; 11(2): 105 - 112. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Hanada, T. Hara, M. Fukasawa, A. Yamaji, M. Umeda, and M. Nishijima Mammalian Cell Mutants Resistant to a Sphingomyelin-directed Cytolysin. GENETIC AND BIOCHEMICAL EVIDENCE FOR COMPLEX FORMATION OF THE LCB1 PROTEIN WITH THE LCB2 PROTEIN FOR SERINE PALMITOYLTRANSFERASE J. Biol. Chem., December 11, 1998; 273(50): 33787 - 33794. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Stapleton, M. R. Stroud, S. I. Hakomori, and W. E. Stamm The Globoseries Glycosphingolipid Sialosyl Galactosyl Globoside Is Found in Urinary Tract Tissues and Is a Preferred Binding Receptor In Vitro for Uropathogenic Escherichia coli Expressing pap-Encoded Adhesins Infect. Immun., August 1, 1998; 66(8): 3856 - 3861. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Henseler, A. Klein, G. J. Glombitza, K. Suziki, and K. Sandhoff Expression of the Three Alternative Forms of the Sphingolipid Activator Protein Precursor in Baby Hamster Kidney Cells and Functional Assays in a Cell Culture System J. Biol. Chem., April 5, 1996; 271(14): 8416 - 8423. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-P. Yan, D. D. Ilsley, C. Frohlick, R. Steet, E. T. Hall, R. D. Kuchta, and P. Melançon 3`-Azidothymidine (Zidovudine) Inhibits Glycosylation and Dramatically Alters Glycosphingolipid Synthesis in Whole Cells at Clinically Relevant Concentrations J. Biol. Chem., September 29, 1995; 270(39): 22836 - 22841. [Abstract] [Full Text] [PDF] |
||||
![]() |
E Nudelman, R Kannagi, S Hakomori, M Parsons, M Lipinski, J Wiels, M Fellous, and T Tursz A glycolipid antigen associated with Burkitt lymphoma defined by a monoclonal antibody Science, April 29, 1983; 220(4596): 509 - 511. [Abstract] [PDF] |
||||
![]() |
P. Fishman and R. Brady Biosynthesis and function of gangliosides Science, November 26, 1976; 194(4268): 906 - 915. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |